PUBLIC CONTRACT · 2019

4180273/2019 - Aq. Central I251 infliximab 100 mg (inflectra) po sol inj

Contract value: €6,862.90
Signed on: 4 June 2019
Procedure: Ao abrigo de acordo-quadro (art.º 258.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 5722332

PUBLISHED SUBJECT

4180273/2019 - AQ. CENTRAL I251 INFLIXIMAB 100 MG (INFLECTRA) PO SOL INJ

Parties involved

Contracting body: Centro Hospitalar Barreiro Montijo, E. P. E.
Awardee: Laboratórios Pfizer
Place of performance: Portugal, Setúbal, Barreiro
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: Laboratórios Pfizer · Tax ID 500162166

Values and timeline

Contract price: €6,862.90
Procedure base price: €6,862.90
Total effective price: €6,862.90
Publication date: 23 July 2019
Award date: 4 June 2019
Signing date: 4 June 2019
Performance period: 5 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Ao abrigo de acordo-quadro (art.º 258.º)
Award criterion: Melhor relação qualidade – preço
CPV code: 33600000-6 - Produtos farmacêuticos
Legal basis: Artigo 258.º do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement: CP 2015/6 - Acordo quadro para o fornecimento de Medicamentos do Foro Oncológico
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 4112151

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts